A pharmaceutical fix for drug resistance
Channel: Wellcome
Date: 15/11/2017

Drug-resistant infections is a priority area for Wellcome. We need new antibiotics, and we need to look after the ones we have more carefully. But every time we take an antibiotic, it risks promoting the development of resistant genes in our gut bacteria.

Ryan Donnelly is Professor of Pharmaceutical Technology at Queen’s University Belfast, and has a Wellcome Collaborative Award to develop microneedles for delivering antibiotics across the skin.
If successful, it will mean we have a way of taking new and existing antibiotics – and other drugs – that is as simple as a pill but doesn’t ever go through the gut.

This is just one great idea that Wellcome supports. For more, take a look at our playlist:
https://www.youtube.com/playlist?list=PL6vkBtYmFlj-zHdEwFq7W-eNlKXTsAVMS 

Find out more about our funding opportunities:
http://wellc.me/2yl9eNc 

Follow us on Twitter: http://twitter.com/wellcometrust
Find us on Facebook: http://www.facebook.com/wellcometrust